Robotic vs. open partial cytoreductive nephrectomy in metastatic renal cell carcinoma: adverse in-hospital outcomes - Scorecard - MDSpire

Robotic vs. open partial cytoreductive nephrectomy in metastatic renal cell carcinoma: adverse in-hospital outcomes

  • By

  • Quynh Chi Le

  • Mattia Longoni

  • Andrea Marmiroli

  • Fabian Falkenbach

  • Calogero Catanzaro

  • Michele Nicolazzini

  • Federico Polverino

  • Jordan A. Goyal

  • Fred Saad

  • Riccardo Schiavina

  • Luca Fabio Carmignani

  • Alberto Briganti

  • Nicola Longo

  • Markus Graefen

  • Carlotta Palumbo

  • Miriam Traumann

  • Felix K.-H. Chun

  • Pierre I. Karakiewicz

  • November 11, 2025

  • 0 min

Share

Clinical Scorecard: Comparative Analysis of Robotic and Open Approaches to Partial Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: In-Hospital Adverse Outcomes

At a Glance

CategoryDetail
ConditionMetastatic renal cell carcinoma (mRCC)
Key MechanismsPartial cytoreductive nephrectomy (PCN) performed via robotic (RPCN) or open (OPCN) surgical approaches
Target PopulationAdult patients (≥18 years) with metastatic renal cell carcinoma undergoing PCN
Care SettingInpatient hospital setting

Key Highlights

  • RPCN rates increased significantly from 4.2% in 2008 to 42.5% in 2019, with an estimated annual increase of 10%.
  • RPCN was associated with significantly lower rates of intraoperative complications, pulmonary complications, blood transfusions, and shorter length of stay compared to OPCN.
  • No significant differences were observed between RPCN and OPCN in overall complications, cardiac, vascular, gastrointestinal complications, total hospital charges, or in-hospital mortality.

Guideline-Based Recommendations

Diagnosis

  • Identify metastatic RCC patients using ICD-9 and ICD-10 codes for RCC and metastatic stage.
  • Select patients undergoing partial cytoreductive nephrectomy using procedure codes for RPCN and OPCN.

Management

  • Consider robotic partial cytoreductive nephrectomy (RPCN) as a surgical option due to lower intraoperative and pulmonary complications and reduced blood transfusion rates.
  • RPCN may contribute to shorter hospital length of stay compared to open approach.

Monitoring & Follow-up

  • Monitor for intraoperative complications, pulmonary complications, and need for blood transfusions postoperatively.
  • Track length of hospital stay and in-hospital mortality as key outcome measures.

Risks

  • No significant difference in overall complication rates or in-hospital mortality between RPCN and OPCN.
  • Potential risks related to surgical approach should be balanced with patient comorbidities and hospital resources.

Patient & Prescribing Data

491 adult patients with metastatic RCC undergoing partial cytoreductive nephrectomy from 2008 to 2019

28% underwent RPCN with increasing adoption over time; RPCN associated with improved in-hospital adverse outcome profile compared to OPCN.

Clinical Best Practices

  • Use propensity score matching and multivariable adjustments to account for confounding factors when comparing surgical approaches.
  • Consider patient and hospital characteristics such as age, sex, comorbidities, hospital teaching status, and region in treatment planning.
  • Adopt robotic surgical techniques where feasible to potentially reduce intraoperative complications and hospital length of stay.

References

Original Source(s)

Related Content